KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,020 | -25.1% | 3,000 | 0.0% | 0.00% | – |
| Q2 2023 | $5,370 | -54.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2023 | $11,670 | +14.4% | 3,000 | 0.0% | 0.00% | – |
| Q4 2022 | $10,200 | -36.2% | 3,000 | 0.0% | 0.00% | – |
| Q3 2022 | $16,000 | +14.3% | 3,000 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -50.0% | 3,000 | -21.1% | 0.00% | – |
| Q1 2022 | $28,000 | +16.7% | 3,800 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | +9.1% | 3,800 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | -43.6% | 3,800 | 0.0% | 0.00% | – |
| Q2 2021 | $39,000 | -78.2% | 3,800 | -77.7% | 0.00% | – |
| Q1 2021 | $179,000 | -31.9% | 17,010 | 0.0% | 0.00% | – |
| Q4 2020 | $263,000 | +378.2% | 17,010 | +347.6% | 0.00% | – |
| Q3 2020 | $55,000 | -23.6% | 3,800 | 0.0% | 0.00% | – |
| Q2 2020 | $72,000 | -1.4% | 3,800 | 0.0% | 0.00% | – |
| Q1 2020 | $73,000 | 0.0% | 3,800 | 0.0% | 0.00% | – |
| Q4 2019 | $73,000 | +97.3% | 3,800 | 0.0% | 0.00% | – |
| Q3 2019 | $37,000 | +60.9% | 3,800 | 0.0% | 0.00% | – |
| Q2 2019 | $23,000 | +4.5% | 3,800 | 0.0% | 0.00% | – |
| Q1 2019 | $22,000 | -38.9% | 3,800 | 0.0% | 0.00% | – |
| Q4 2018 | $36,000 | +300.0% | 3,800 | +660.0% | 0.00% | – |
| Q3 2018 | $9,000 | +12.5% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | +14.3% | 500 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |